IDF working on new guidelines to treat Type 2 Diabetes

What is Type 2 Diabetes?

• Type 2 Diabetes is a chronic condition where the body becomes resistant to insulin or doesn’t produce enough, leading to high blood sugar levels.
• It is commonly linked to obesity, physical inactivity and poor diet.
• Symptoms include increased thirst, frequent urination, fatigue, and blurred vision.
• Treatment involves lifestyle changes like a healthy diet, regular exercise, and weight management.
  • Medications such as Metformin help regulate blood sugar levels, and in some cases, insulin therapy may be required.

• Established in 1950; Brussels, Belgium;
• Members: Over 230 national diabetes associations in 170 countries and territories.
• Collaborations: Partners with global organizations like the World Health Organization (WHO), UNICEF, and others for global health initiatives.
• Led by an elected President with the support of a Board of Directors from member countries.
• Regional offices: Operates regional offices in Africa, Europe, North America, Asia, Latin America, and the Middle East.

• To improve the care and lives of people with diabetes and promote its prevention worldwide.
• Advocacy, research, education, and raising awareness to reduce the global burden of diabetes.

• World Diabetes Day (November 14)
• Global Diabetes Atlas
• Educational initiatives for healthcare professionals

• Type 1 Diabetes: Primarily affects children and young adults, where the body’s immune system attacks the insulin-producing cells in the pancreas.
• Type 2 Diabetes: The most common form, often linked to lifestyle factors and obesity. It involves insulin resistance and eventually pancreas dysfunction.
• Gestational Diabetes: A type of diabetes that occurs during pregnancy and increases the risk of developing Type 2 diabetes later in life.
• Other Forms: Covers genetic forms, latent autoimmune diabetes in adults (LADA), and MODY (Maturity Onset Diabetes of the Young).